ENC006
Pre-clinical- Indications
- Central nervous system disorders
Company intelligence / Profile preview
EnClear Therapies
Cambridge, Massachusetts, United Statesencleartherapies.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
EnClear Therapies has developed a proprietary platform for precision delivery of therapeutics to the central nervous system via cerebrospinal fluid. The company’s lead programs are in pre-clinical development targeting neuro-oncology indications such as leptomeningeal carcinomatosis. The technology aims to improve therapeutic efficacy while reducing side effects by enabling controlled and continuous drug delivery directly to affected areas in the CNS. Recent funding rounds have supported advancement toward first-in-human studies.
- Therapeutic areas
- ImmunologyOncologyRare DiseasesNeurology
- Modalities
- Device-based therapies (precision dosing and CSF management)Potentially combination with small molecules or biologics delivered via CSF
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
QurAlis Therapeutics (collaboration on combining technologies for brain drug delivery)Strategic partnerships within pharmaceutical sector mentioned but not specified by name
Beyond the preview
Go deeper on EnClear Therapies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EnClear Therapies.